Advertisement
Advertisement
February 27, 2012
Control Medical's Aspire Max Thrombus Aspiration System Cleared by FDA
February 28, 2012—Control Medical Technology (Park City, UT) announced that the US Food and Drug Administration has granted clearance for the company to market its Aspire Max thrombus aspiration system. The Aspire Max is described by Control Medical as a high-performance aspirator with integrated handles and valves that allow clinicians to instantly create, increase, decrease, slow, stop, or "pulse" aspiration force.
According to a company press release, the FDA clearance allows Control Medical to market the Aspire Max thrombus aspiration catheter system including an Aspire aspirator and a Max catheter in one package and/or Max aspiration catheters alone in multiple sizes with an indication to remove soft fresh thrombi, and emboli, from vessels in the peripheral vasculature.
The Max thrombus large-lumen catheters are available in multiple outer diameters and lengths and are designed to improve aspiration speed, force, and control.
Advertisement
Advertisement
